Ignite Creation Date:
2024-05-05 @ 12:00 PM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00209430
Status:
COMPLETED
Last Update Posted:
2007-10-31
First Post:
2005-09-13
Brief Title:
Renal Effects of Two Iodinated Contrast Media in Patients at Risk Undergoing Coronary Angiography
Sponsor:
GE Healthcare
Organization:
GE Healthcare
Study Overview
Official Title:
GEHC Has Decided Not to Provide This Detail But Will Rely on the Brief Title
Status:
COMPLETED
Status Verified Date:
2007-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The main purpose of this study is to evaluate and compare the effects on kidney function of two contrast media the iso-osmolar iodixanol and the low-osmolar iopamidol in patients at risk of kidney damage associated with the injection of contrast media A standard hydration procedure based on available guidelines will be given to all patients to prevent negative effects on the kidneys Serum creatinine SCr concentrations will be measured before and up to 7 days after contrast media administration to evaluate the effects on renal function
Detailed Description:
GEHC has decided not to provide this detail
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None